Palumbo Wealth Management LLC Inozyme Pharma, Inc. Transaction History
Palumbo Wealth Management LLC
- $289 Million
- Q1 2025
A detailed history of Palumbo Wealth Management LLC transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Palumbo Wealth Management LLC holds 29,784 shares of INZY stock, worth $34,549. This represents 0.01% of its overall portfolio holdings.
Number of Shares
29,784
Previous 23,281
27.93%
Holding current value
$34,549
Previous $64,000
57.81%
% of portfolio
0.01%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding INZY
# of Institutions
105Shares Held
50.6MCall Options Held
2.6KPut Options Held
5.1K-
Adage Capital Partners Gp, L.L.C. Boston, MA5.16MShares$5.99 Million0.03% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA4.49MShares$5.21 Million11.45% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA4.28MShares$4.97 Million0.97% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.97MShares$4.61 Million1.97% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD3.86MShares$4.48 Million0.43% of portfolio
About Inozyme Pharma, Inc.
- Ticker INZY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,145,700
- Market Cap $46.6M
- Description
- Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...